Elizabeth Shaffer

Manager, Regulatory Affairs

Biography

Elizabeth Shaffer is the Regulatory Affairs Manager for the Alzheimer’s Clinical Trials Consortium (ACTC) and for the Alzheimer’s Therapeutic Research Institute (ATRI) at the University of Southern California. Ms. Shaffer and the Regulatory Affairs team provides regulatory management and oversight for all ACTC and ATRI clinical trials and research studies, ensuring regulatory compliance all studies. Ms. Shaffer is responsible for the development of the study informed consent form documents, regulatory health authority submissions, central IRB submissions and registration of trials on ClinicalTrials.gov. She is a member of the ACTC Research Participant Advisory Board Task Force, NIH’s Participant FIRST Post-Trial Subcommittee, and NIH’s Law and Ethics Subgroup of the Genetic and Biomarker Disclosure Work Group, groups that seek to put the participant first in clinical trial research from trial design, implementation, and completion.

Paul Aisen received his B.A. in biochemistry and molecular biology from Harvard and his medical degree from Columbia. He completed his residency at Case Western Reserve University in Cleveland and Mount Sinai Medical Center in New York, and then fellowship training in rheumatology at New York University.

Videos

Publications

Contribution of Alzheimer’s biomarkers and risk factors to cognitive impairment and decline across the Alzheimer’s disease continuum Alzheimers Dement.

Contribution of Alzheimer’s biomarkers and risk factors to cognitive impairment and decline across the Alzheimer’s disease continuum Alzheimers Dement.

Contribution of Alzheimer’s biomarkers and risk factors to cognitive impairment and decline across the Alzheimer’s disease continuum Alzheimers Dement.

Contribution of Alzheimer’s biomarkers and risk factors to cognitive impairment and decline across the Alzheimer’s disease continuum Alzheimers Dement.

Contribution of Alzheimer’s biomarkers and risk factors to cognitive impairment and decline across the Alzheimer’s disease continuum Alzheimers Dement.

Achievements & Honors

Nunc donec sagittis condimentum nam. Fames faucibus cras eleifend fusce id. Fermentum quam neque, risus, eget. Enim morbi tempus eget aliquet fringilla quis. Ultrices arcu ornare eget cras enim. Est blandit tristique porta senectus amet velit sagittis pharetra ipsum. Sed augue augue enim orci porta eget condimentum.

Research Interests

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Principal Investigator for

Connect

News